首页 | 本学科首页   官方微博 | 高级检索  
检索        


Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial‐onset seizures: Results of a phase III,double‐blind,randomized, placebo‐controlled trial
Authors:Michael R Sperling  Bassel Abou‐Khalil  Jay Harvey  Joanne B Rogin  Arnaud Biraben  Carlo A Galimberti  Pedro A Kowacs  Seung Bong Hong  Hailong Cheng  David Blum  Teresa Nunes  Patrício Soares‐da‐Silva  the Study Team
Institution:1. Thomas Jefferson University, Philadelphia, Pennsylvania, U.S.A;2. Vanderbilt University Medical Center, Nashville, Tennessee, U.S.A;3. Texas Epilepsy Group, Dallas, Texas, U.S.A;4. Midwest Center for Seizure Disorders, Minneapolis Clinic of Neurology, Golden Valley, Minnesota, U.S.A;5. C.H.U. de Rennes, Rennes, France;6. I.R.C.C.S., C. Mondino National Neurological Institute, Pavia, Italy;7. Curitiba Neurological Institute, Curitiba, Brazil;8. Samsung Medical Center, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Seoul, South Korea;9. Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts, U.S.A;10. BIAL‐Portela & Ca S.A., S. Mamede do Coronado, Portugal;11. MedInUP – Center for Drug Discovery and Innovative Medicines, University of Porto, Porto, Portugal
Abstract:
Keywords:Adjunctive therapy  Antiepileptic drugs  Eslicarbazepine acetate  North America  Partial‐onset seizures  Refractory epilepsy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号